Skip to main content
Signal8

IGC Pharma, Inc. (IGC)

Sector: Pharmaceutical Preparations

Industry: Biotechnology

IGC Pharma, Inc. logo

IGC Pharma, Inc.

NYSE:IGCHealthcare
AH+0.00%$0.2044
Close$0.2044+2.20%
Mkt Cap$23.85M
Float88.19M
O/S116.69M
VOL396K sh
$ Vol$80K
RVOL0.73×
Inst Own4.8%
SI0.7%
EarningsNov 18 · in 1w
Dilution
IGC Pharma, Inc. logoNYSE:IGCAH$0.2044+0.00%
Historical Data
DateOpenHighLowCloseVolume
Nov 9, 20260.19400.20600.19300.2044396,325
Nov 6, 20260.19100.20190.18060.2000615,170
Nov 5, 20260.19680.19880.17850.1890842,969
Nov 4, 20260.19120.19500.18520.1950329,770
Nov 3, 20260.19270.20000.18500.1860351,402
Nov 2, 20260.20000.20000.18510.1929397,985
Oct 30, 20260.19100.19700.18080.1850523,101
Oct 29, 20260.24500.24500.08000.19922,018,955
Oct 28, 20260.25000.25070.23770.2387510,522
Oct 27, 20260.24600.25000.24500.2479142,296
Oct 26, 20260.24500.25700.24100.2499331,049
Oct 23, 20260.24830.25000.24300.2460124,238
Oct 22, 20260.24500.25000.24300.2477180,440
Oct 21, 20260.24580.25000.24040.2425368,323
Oct 20, 20260.24090.25470.24010.2450447,569
Oct 19, 20260.25190.26590.23500.2420541,214
Oct 16, 20260.26000.26000.24200.2460409,776
Oct 15, 20260.26000.26270.25000.2541782,399
Oct 14, 20260.26000.26200.25000.2519947,576
Oct 13, 20260.26960.27100.26000.2650422,365
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
2
HOLD
0
SELL
0
TOTAL2
Insider Trades
InsiderTypeShares
GRIMALDI CLAUDIA profile photoGRIMALDI CLAUDIAWithholding/Transfer150.0K
Mukunda Ram profile photoMukunda RamWithholding/Transfer100.0K
Mukunda Ram profile photoMukunda RamWithholding/Transfer100.0K
Mukunda Ram profile photoMukunda RamGrant/Award2.23M
GRIMALDI CLAUDIA profile photoGRIMALDI CLAUDIAGrant/Award2.05M
Moran James P profile photoMoran James POption Exercise50.0K
Shareholders
4.8%
Institutional
(34)
10.9%
Insiderⓘ
(4)
11.8%
5%+ Owners
(1)
of which 11.8% rests on schedules older than 24 months (1 holder)
72.5%
Unattributed (incl. retail)ⓘ
Institutional4.8%
Insider10.9%
5%+ Beneficial11.8%
Unattributed (incl. retail)72.5%
Top Shareholders
NameShares%
Bradbury Strategic Investment Fund A logo
Bradbury Strategic Investment Fund A
· may incl. warrants· stale · filed Aug 2024
13.8M11.8%
Mukunda Ram profile photo
Mukunda Ram
CEO, Director
6.7M5.7%
GRIMALDI CLAUDIA profile photo
GRIMALDI CLAUDIA
PFO, Director
3.3M2.8%
PRINS RICHARD K profile photo
PRINS RICHARD K
Director
1.5M1.3%
Moran James P profile photo
Moran James P
Director
1.2M1.1%
GEODE CAPITAL MANAGEMENT, LLC logo
GEODE CAPITAL MANAGEMENT, LLC
1.0M0.9%
AdvisorShares Investments LLC logo
AdvisorShares Investments LLC
939.5K0.8%
VANGUARD CAPITAL MANAGEMENT LLC logo
VANGUARD CAPITAL MANAGEMENT LLC
814.9K0.7%
BlackRock, Inc. logo
BlackRock, Inc.
703.8K0.6%
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
437.3K0.4%
Sources: 13F, Form 4, 13D/13GO/S: 116.7M · as of 3 Nov 2026 · SEC filings
Insiders & Institutional Holders

Insiders

Top institutional holders

About

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness.

It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.

In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research.

The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

Key Metrics
Market Cap$23.85M
Enterprise Value--
P/E Ratio-5.32
Est. Net Cash/Share--
Institutional Ownership4.76%

based on 116.69M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeNYSE American
CountryUSUS
IPO DateMay 24, 2006
Shares Outstanding116.69M
Authorized Shares
Float88.19M
SEC Float (non-affiliate)88.41M
52-Week Range
$0.0800$0.4041
$0.2044(38th percentile)
Volume
Average Daily Volume543.03K
396.32K today vs 543.03K avg(-27%)

30d Avg

543.03K

60d Avg

606.62K

90d Avg

740.11K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...